Physician

Gary A Buxa, M.D.

According to 2025 Medicare claims, Gary Buxa, M.D. (NPI: 1013991124) practices otolaryngology in the Redding, CA market, with the plurality of this provider's patient population coming from Shasta, CA. Buxa uses personal NPI as billing NPI and primary practice location at 96001-2364.

Buxa's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,145 traditional Medicare patients, billed 11,120 HCPCS/CPT codes, and received $731,786 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,225 prescription claims across 480 beneficiaries totaling $90,280 in drug costs, led by Dupixent Pen (Dupilumab). 2017 DME data shows 14 claims. Open Payments data shows 19 records totaling $581. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $259,183 to $731,786. Similarly, Part D prescription costs have moved sharply higher in recent years, from $41,543 to $90,280. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $2,354 to $527.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,062	5,423	$259,183
2016	1,114	5,211	$288,170
2017	1,152	4,842	$263,781
2018	1,113	5,213	$287,502
2019	1,098	5,570	$316,177
2020	1,012	5,415	$287,608
2021	1,104	9,463	$356,897
2022	1,067	10,327	$351,755
2023	1,091	10,216	$418,278
2024	1,145	11,120	$731,786

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	281	706	$41,543
2016	293	700	$42,351
2017	313	797	$40,498
2018	296	699	$34,386
2019	335	816	$29,365
2020	293	838	$24,419
2021	315	778	$25,106
2022	344	831	$25,237
2023	377	1,070	$33,350
2024	480	1,225	$90,280

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$770
2016	N/R	N/R	N/R
2017	N/R	14	$2,719
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	383	383	$118
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	368	456	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	400	502	$66
92557	Comprehensive hearing and speech recognition test	385	409	$28
92567	Test to assess middle ear function	398	430	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dupixent Pen	Dupilumab	16	448	$57,899
Epinephrine	Epinephrine	35	794	$6,900
Fluocinolone Acetonide Oil	Fluocinolone Acetonide Oil	158	17,972	$4,967
Ipratropium Bromide	Ipratropium Bromide	155	5,390	$4,567
Fluticasone Propionate	Fluticasone Propionate	307	14,654	$3,771

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$581	Inspire Medical Systems, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Gary A. Buxa, M.D.?

Tedicare shows public-source Medicare data for Gary A. Buxa, M.D. (NPI 1013991124), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gary A. Buxa, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gary A. Buxa, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Gary A. Buxa, M.D. have Open Payments data?

Gary A. Buxa, M.D. has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.